Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (42)
Article
How to have a data-driven discussion on gene and cellular therapies
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.
Read MoreArticle
Gene therapies, today and tomorrow
April 12, 2024
By supporting and encouraging evidence-based access to gene therapy, payers and other segments of U.S. society will be positioned to benefit from future advancements and biopharmaceutical breakthrough...
Article
As more gene therapies come to market, payers need expanded options to protect their plans
August 28, 2024
Article
Addressing the growing impact of gene therapies on employer plans
August 18, 2025
As the gene therapy market evolves, it’s more important than ever for employers to put the right gene therapy management program in place.
Article
Leveraging data, insights, and clinical expertise to support gene and cell therapy treatment
August 28, 2025
Learn more about Evernorth Therapy Link, a new solution designed to identify and support patients who can benefit most from gene or cell therapies.
Article
Understanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read MoreArticle
Specialty pipeline perspectives: Meeting the needs of patients with diverse neurological conditions
June 19, 2025
At Accredo by Evernorth, we’re witnessing a transformation in neurological care as innovative treatments move from research to reality.